Cite
HARVARD Citation
Moussa, C. et al. (n.d.). A novel small molecule tyrosine kinase inhibitor (GUtinib) preferentially targets discoidin domain receptors and reduces toxic proteins in neurodegeneration. Parkinsonism & related disorders. pp. e67-. [Online].